AbbVie's blockbuster drug Humira finally loses its 20-year, $200B monopoly

By NPR
| February 01, 2023

This week California-based biotech firm Amgen released Amjevita, the first close copy of the best selling drug of all time. At least seven more Humira biosimilars are expected to debut later this year.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...